Here's what SURMOUNT-5 found in 751 adults with obesity (without type 2 diabetes) over 72 weeks: Tirzepatide group: Average weight loss of 20.2% Semaglutide group: Average weight loss of 13.7% That's a meaningful difference roughly 6.5 percentage points
Recalls & Warnings August 29, 2017 FDA Warns Seller of Supplements for Allergies, Joint Pain, Bone Health, and More On August 16, 2017, the FDA issued a warning letter to Total Nutrition, Inc
Uh, you just can't market it
What Did the 2025 Meta-Analysis Find About B12 Delivery Methods
Theyre not magic, but when paired with proper nutrition, sleep, and hormone evaluation, they often make fat loss feel possible again instead of frustrating
Individuals in Tyde Wellness programs indicate an average body reduction of 15% after 68 weeks